This session will review recent translational and clinical data, including recent clinical trials results, to provide state of the art clinical perspective of new developments in prevention strategies, diagnostics and management of M. avium complex (MAC) and M. abscessus complex (MAbsC) lung disease, as well as of latent, incipient and subclinical TB infections, and multidrug-resistant TB in various groups of patients and settings.
• Learn new diagnostic and therapeutic strategies, for the best management of patients with complex MAC- and MAbsC-lung disease, including novel and emergent treatment interventions in the United States and abroad
• Learn new concepts from recent studies to optimally diagnose and manage latent, incipient, and subclinical TB infection in special settings in TB endemic areas and non-endemic areas
• Learn new concepts from recent studies to optimally diagnose and manage patients with TB and MDR-TB/pre-XDR-TB (and their contacts) based on recent WHO guidelines, ATS/IDSA guidelines, and recent clinical trials data
Charles Daley, MD
Margareth Dalcolmo, MD, PhD
Patricio Escalante, MD, MSc
Connie Haley, MD, MPH
MAC Pulmonary Disease: Evolving Concepts and Best Individualized Management
M. Abscessus Complex Pulmonary Disease: Novel Treatment Interventions and Individualized Approach
Diagnostics and Therapeutic Interventions in Latent, Incipient, and Subclinical TB Infections - Presentation withheld at the speaker's request
TB and MDR-TB: Evolving Concepts and Recent Guidelines-Based Therapies